Terms: = Germ cell tumor AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
103 results:
1. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere MR; Spiegelman VS
Front Immunol; 2024; 15():1385875. PubMed ID: 38660306
[TBL] [Abstract] [Full Text] [Related]
2. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report.
Kompani F; Safari Sharari A; Haji Esmaeil Memar E; Ghahremanloo M
Arch Iran Med; 2024 Jan; 27(1):44-47. PubMed ID: 38431960
[TBL] [Abstract] [Full Text] [Related]
3. Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome.
Hammad R; Selim M; Eldosoky MA; Elmadbouly AA; Abd El Hakam FE; Elshafei A; Fawzy M; Hammad M
Pathol Res Pract; 2024 Feb; 254():155060. PubMed ID: 38194805
[TBL] [Abstract] [Full Text] [Related]
4. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
5. Retroperitoneal localized neuroblastoma in children: a comparison of enhanced recovery after surgery versus traditional care.
Zhu K; He J; Chen T; Yu X; He X; Su Y
Pediatr Surg Int; 2023 Jun; 39(1):208. PubMed ID: 37261573
[TBL] [Abstract] [Full Text] [Related]
6. RBBP4 regulates the expression of the Mre11-Rad50-nbs1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance.
Li J; Song C; Gu J; Li C; Zang W; Shi L; Chen L; Zhu L; Zhou M; Wang T; Li H; Qi S; Lu Y
Cancer Lett; 2023 Mar; 557():216078. PubMed ID: 36736531
[TBL] [Abstract] [Full Text] [Related]
7. nbn Pathogenic germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract] [Full Text] [Related]
8. MYCN and HIF-1 directly regulate
Hains AE; Uppal S; Cao JZ; Salwen HR; Applebaum MA; Cohn SL; Godley LA
Epigenetics; 2022 Dec; 17(13):2056-2074. PubMed ID: 35942521
[TBL] [Abstract] [Full Text] [Related]
9. Inherited germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Pietzak EJ; Whiting K; Srinivasan P; Bandlamudi C; Khurram A; Joseph V; Walasek A; Bochner E; Clinton T; Almassi N; Truong H; de Jesus Escano MR; Wiseman M; Mandelker D; Kemel Y; Zhang L; Walsh MF; Cadoo KA; Coleman JA; Al-Ahmadie H; Rosenberg JE; Iyer GV; Solit DB; Ostrovnaya I; Offit K; Robson ME; Stadler ZK; Berger MF; Bajorin DF; Carlo M; Bochner BH
Clin Cancer Res; 2022 Oct; 28(19):4267-4277. PubMed ID: 35833951
[TBL] [Abstract] [Full Text] [Related]
10. Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.
Lim YC; Jensen KE; Aguilar-Morante D; Vardouli L; Vitting-Seerup K; Gimple RC; Wu Q; Pedersen H; Elbaek KJ; Gromova I; Ihnatko R; Kristensen BW; Petersen JK; Skjoth-Rasmussen J; Flavahan W; Rich JN; Hamerlik P
Neuro Oncol; 2023 Feb; 25(2):248-260. PubMed ID: 35608632
[TBL] [Abstract] [Full Text] [Related]
11. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
12. Development and Validation of Arc Nanobodies: New Tools for Probing Arc Dynamics and Function.
Ishizuka Y; Mergiya TF; Baldinotti R; Xu J; Hallin EI; Markússon S; Kursula P; Bramham CR
Neurochem Res; 2022 Sep; 47(9):2656-2666. PubMed ID: 35307777
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review.
Jin QY; Du SB; Yuan XJ
Neoplasma; 2022 Mar; 69(2):464-473. PubMed ID: 35068159
[TBL] [Abstract] [Full Text] [Related]
14. Current thoracoscopic approach for mediastinal neuroblastoma in Japan-results from nationwide multicenter survey.
Kawano T; Souzaki R; Sumida W; Shimojima N; Hishiki T; Kinoshita Y; Uchida H; Tajiri T; Yoneda A; Oue T; Kuroda T; Hirobe S; Koshinaga T; Hiyama E; Nio M; Inomata Y; Taguchi T; Ieiri S
Pediatr Surg Int; 2021 Dec; 37(12):1651-1658. PubMed ID: 34448929
[TBL] [Abstract] [Full Text] [Related]
15. Neuroblastoma xenograft models demonstrate the therapeutic potential of
Romiani A; Spetz J; Shubbar E; Lind DE; Hallberg B; Palmer RH; Forssell-Aronsson E
BMC Cancer; 2021 Aug; 21(1):950. PubMed ID: 34433438
[TBL] [Abstract] [Full Text] [Related]
16. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming.
Tao L; Moreno-Smith M; Ibarra-García-Padilla R; Milazzo G; Drolet NA; Hernandez BE; Oh YS; Patel I; Kim JJ; Zorman B; Patel T; Kamal AHM; Zhao Y; Hicks J; Vasudevan SA; Putluri N; Coarfa C; Sumazin P; Perini G; Parchem RJ; Uribe RA; Barbieri E
Adv Sci (Weinh); 2021 Oct; 8(19):e2005047. PubMed ID: 34365742
[TBL] [Abstract] [Full Text] [Related]
17. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract] [Full Text] [Related]
18. The quest to develop an effective therapy for neuroblastoma.
Bhoopathi P; Mannangatti P; Emdad L; Das SK; Fisher PB
J Cell Physiol; 2021 Nov; 236(11):7775-7791. PubMed ID: 33834508
[TBL] [Abstract] [Full Text] [Related]
19. Therapeutic depletion of CCR8
Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
[TBL] [Abstract] [Full Text] [Related]
20. Long-Term Near-Infrared Signal Tracking of the Therapeutic Changes of Glioblastoma cells in Brain Tissue with Ultrasound-Guided Persistent Luminescent Nanocomposites.
Cheng CL; Chan MH; Feng SJ; Hsiao M; Liu RS
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6099-6108. PubMed ID: 33507729
[TBL] [Abstract] [Full Text] [Related]
[Next]
